IR@PKUHSC  > 北京大学第三临床医学院
学科主题临床医学
Association of CYP3A4*18B polymorphisms with the pharmacokinetics of cyclosporine in healthy subjects
Hu, Y.-F.; Tu, J.-H.; Tan, Z.-R.; Liu, Z.-Q.; Zhou, G.; He, J.; Wang, D.; Zhou, H.-H.
关键词Cyp3a4 Polymorphisms Cyclosporine Pharmacokinetics
刊名XENOBIOTICA
2007-03-01
DOI10.1080/00498250601149206
37期:3页:315-327
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Pharmacology & Pharmacy ; Toxicology
研究领域[WOS]Pharmacology & Pharmacy ; Toxicology
关键词[WOS]HUMAN-LIVER ; CYP3A4 ; IDENTIFICATION ; CHINESE ; CYTOCHROME-P-450 ; METABOLISM ; REJECTION ; CYP2C19 ; PHARMACOGENOMICS ; INHIBITORS
英文摘要

The aim of this study is to evaluate the association of the CYP3A4(*) 18B genotype with the cyclosporine metabolism in healthy subjects. We employed PCR RFLP assays for analysis of the CYP3A4(*)18B genotype. Each of 26 subjects, comprising 12 CYP3A4(*)1/(*)l, 12 CYP3A4(*)1/(*)18B and 2 CYP3A4(*)18B/(*)18B, was given a single oral dose of cyclosporine (4mgkg(-1)). The plasma concentrations of cyclosporine were measured for up to 24h post dose by high-performance liquid chromatography-electrospray mass spectrometry. We found that the mean C-max (95% confidence intervals) of cyclosporine were 2237 (2905, 1859) ((*)1/(*)1), 2247 (2916, 1869) ((*)1/(*)18B), and 905 (1192,506) ngml(-1) ((*)18B/(*1)8B)(p=0.037) and the mean AUCO-4were 5026 (6181, 4372) ((*)1/(*)1), 4434 (5481, 3841) ((*)1/(*)18B) and 2561 (3155, 1736) ng ml-1 h ((*)18B/(*)18B)(p=0.02l). The CL in the (*)18B/(*)18B group was significantly higher than in the (*)1/(*)1 group. However, T-maz exhibited no difference among the three genotypes. (*)18B/(*)18B group showed 50% reduction in concentration at 2h post dose compared with (*)1/(*)18B (p=0.062) or (*)1/(*)1 (p=0.047), but no statistical significance was detected between *1/(*)1 and *1/*18B groups (p > 0.05). The data suggest that the CYP3A4(*)18B genotype affects cyclosporine pharmacokinetics probably resulting from a higher enzymatic activity of this mutation in healthy subjects.

语种英语
WOS记录号WOS:000245984500007
引用统计
被引频次:45[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/56128
专题北京大学第三临床医学院
作者单位1.Cent S Univ, Inst Clin Pharmacol, Pharmacogenet Res Inst, Changsha 410078, Hunan, Peoples R China
2.Peking Univ, Hosp 3, Beijing 100871, Peoples R China
推荐引用方式
GB/T 7714
Hu, Y.-F.,Tu, J.-H.,Tan, Z.-R.,et al. Association of CYP3A4*18B polymorphisms with the pharmacokinetics of cyclosporine in healthy subjects[J]. XENOBIOTICA,2007,37(3):315-327.
APA Hu, Y.-F..,Tu, J.-H..,Tan, Z.-R..,Liu, Z.-Q..,Zhou, G..,...&Zhou, H.-H..(2007).Association of CYP3A4*18B polymorphisms with the pharmacokinetics of cyclosporine in healthy subjects.XENOBIOTICA,37(3),315-327.
MLA Hu, Y.-F.,et al."Association of CYP3A4*18B polymorphisms with the pharmacokinetics of cyclosporine in healthy subjects".XENOBIOTICA 37.3(2007):315-327.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Hu, Y.-F.]的文章
[Tu, J.-H.]的文章
[Tan, Z.-R.]的文章
百度学术
百度学术中相似的文章
[Hu, Y.-F.]的文章
[Tu, J.-H.]的文章
[Tan, Z.-R.]的文章
必应学术
必应学术中相似的文章
[Hu, Y.-F.]的文章
[Tu, J.-H.]的文章
[Tan, Z.-R.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。